ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,495.07
-0.22%
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.49%
US Dollar vs Yen
157.706
0.10%
Brent Oil
83.90
2.16%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Agios Pharmaceuticals Inc (AGIO)

  7. Agios Pharmaceuticals Inc (AGIO) ニュース

AGIO

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AGIO
日付受信時刻ニュースソース見出しコード企業名
2024/06/1806 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/1806 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/1806 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/1806 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/1806 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/1806 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/1521 : 45GlobeNewswire Inc.Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid CongressNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/0805 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/0622 : 00GlobeNewswire Inc.Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ETNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/0608 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/0605 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/06/0319 : 30GlobeNewswire Inc.Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-ThalassemiaNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/3105 : 05GlobeNewswire Inc.Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/2820 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/2820 : 00GlobeNewswire Inc.Agios Announces $905 Million Purchase Agreement for Vorasidenib RoyaltyNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/1423 : 00GlobeNewswire Inc.Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid CongressNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/0620 : 00GlobeNewswire Inc.Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/0320 : 00GlobeNewswire Inc.Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
2024/05/0220 : 00GlobeNewswire Inc.Agios Reports Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/04/1820 : 00GlobeNewswire Inc.Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
2024/04/0920 : 00GlobeNewswire Inc.Agios Publishes 2024 Environmental, Social and Governance (ESG) ReportNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0808 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0606 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0606 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0606 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0606 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0606 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0521 : 00GlobeNewswire Inc.Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024NASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0206 : 27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
2024/03/0206 : 26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AGIOAgios Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AGIO

最近閲覧した銘柄

NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLF
Financial Select Sector
NYSE
CVX
Chevron
USI
USTECH100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
AMEX
SPY
SPDR S&P 500
CCOM
US30
US 30
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
NYSE
BAC
Bank of America
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
FX
USDEUR
US Dollar vs Euro
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有